• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Active sensitization and occupational allergic contact dermatitis caused by para-tertiary-butylcatechol.

作者信息

Estlander T, Kostiainen M, Jolanki R, Kanerva L

机构信息

Finnish Institute of Occupational Health, (FIOH), Helsinki, Finland.

出版信息

Contact Dermatitis. 1998 Feb;38(2):96-100. doi: 10.1111/j.1600-0536.1998.tb05659.x.

DOI:10.1111/j.1600-0536.1998.tb05659.x
PMID:9506222
Abstract

Para-tertiary-butylcatechol (PTBC) is a rare allergen which is used in the rubber, paint and petroleum industries. We present 9 patients who were sensitized to PTBC and examined at the Finnish Institute of Occupational Health (FIOH) between 1974 and 1995. 3 of the patients had been exposed to PTBC in their work. 2 of them also had allergic reactions to para-tertiary-butylphenol (PTBP)-formaldehyde resin and to PTBP. 5 of the patients became sensitized to PTBC from patch testing. PTBC was found to be one of the most common causes of active sensitization in our clinic. Accordingly, at the FIOH, the patch test concentration of PTBC was lowered to 0.25% and this lower concentration is recommended for general use.

摘要

相似文献

1
Active sensitization and occupational allergic contact dermatitis caused by para-tertiary-butylcatechol.
Contact Dermatitis. 1998 Feb;38(2):96-100. doi: 10.1111/j.1600-0536.1998.tb05659.x.
2
Analysis of patients with allergic patch test reactions to a plastics and glues series.对塑料和胶水系列进行变应原贴片试验反应的患者分析。
Contact Dermatitis. 1995 Jun;32(6):346-51. doi: 10.1111/j.1600-0536.1995.tb00623.x.
3
Allergic contact dermatitis due to para-tertiary-butylcatechol in a resin operator.
Australas J Dermatol. 1999 Feb;40(1):49-50. doi: 10.1046/j.1440-0960.1999.00318.x.
4
Allergic contact dermatitis from para-tertiary-butylphenol-formaldehyde resin (PTBP-F-R) in Northern Ireland.北爱尔兰对叔丁基苯酚甲醛树脂(PTBP-F-R)引起的变应性接触性皮炎。
Contact Dermatitis. 1993 Sep;29(3):144-6. doi: 10.1111/j.1600-0536.1993.tb03512.x.
5
Simultaneous p-tert-butylphenol-formaldehyde resin and p-tert-butylcatechol contact allergies in man and sensitizing capacities of p-tert-butylphenol and p-tert-butylcatechol in guinea pigs.
J Occup Environ Med. 1999 Jan;41(1):23-8. doi: 10.1097/00043764-199901000-00005.
6
Demonstration of the contact sensitizer p-tert-butylcatechol in p-tert-butylphenol formaldehyde resin.
Am J Contact Dermat. 1999 Mar;10(1):2-6. doi: 10.1016/s1046-199x(99)90086-6.
7
Occupational dermatoses among fibreglass-reinforced plastics factory workers.玻璃纤维增强塑料厂工人的职业性皮肤病
Contact Dermatitis. 2002 Jun;46(6):339-47. doi: 10.1034/j.1600-0536.2002.460604.x.
8
Occupational allergic contact dermatitis from formaldehyde resin in clothing.衣物中甲醛树脂引起的职业性变应性接触性皮炎
Contact Dermatitis. 2001 Feb;44(2):109-10. doi: 10.1034/j.1600-0536.2001.44020911.x.
9
Patch-test reactions to plastic and glue allergens.对塑料和胶水过敏原的斑贴试验反应
Acta Derm Venereol. 1999 Jul;79(4):296-300. doi: 10.1080/000155599750010706.
10
Tert-butylhydroquinone and tert-butylcatechol positivity as warning lights of skin sensitization to tert-butylphenol derivatives in adhesives and diabetes devices.叔丁基对苯二酚和叔丁基邻苯二酚呈阳性作为胶粘剂和糖尿病设备中叔丁基苯酚衍生物皮肤致敏的警告信号。
Contact Dermatitis. 2024 Nov;91(5):387-391. doi: 10.1111/cod.14670. Epub 2024 Aug 21.

引用本文的文献

1
Longitudinal Exposomics in a Multiomic Wellness Cohort Reveals Distinctive and Dynamic Environmental Chemical Mixtures in Blood.多组学健康队列中的纵向暴露组学研究揭示了血液中独特且动态的环境化学混合物。
Environ Sci Technol. 2024 Sep 17;58(37):16302-16315. doi: 10.1021/acs.est.4c05235. Epub 2024 Sep 5.
2
Epicutaneous Patch Testing in Type IV Allergy Diagnostics: State of the Art and Best Practice Recommendations.皮内贴斑试验在 IV 型过敏诊断中的应用:现状和最佳实践推荐。
Handb Exp Pharmacol. 2022;268:405-433. doi: 10.1007/164_2021_508.